Efficacy of generic forms of itraconazole capsule in treating subjects with chronic pulmonary aspergillosis.
Inderpaul Singh SehgalKeshavamurthy VinaySahajal DhooriaValliappan MuthuKuruswamy Thurai PrasadAshutosh Nath AggarwalArunaloke ChakrabartiShivaprakash Mandya RudramurthyHansraj ChoudharyRitesh AgarwalPublished in: Mycoses (2023)
At 2 weeks, a significantly higher proportion of CPA subjects achieved therapeutic drug levels with the innovator than the generic itraconazole. The mean serum itraconazole levels independently predicted a favourable treatment response in CPA.